中药及其活性成分对瞬时受体电位通道的调控
本文综述中药及其活性成分对瞬时受体电位(TRP)离子通道的调控作用,并探讨其与中药寒热温凉平药性的关联。作者在寒热温凉平药性中药中梳理出29种对TRP通道有调控作用的中药,包括肉桂、辣椒、大黄、博落回、薄荷、红景天等。原文指出,中药调控TRP通道的分子机制仍需进一步研究。
要点
- TRP通道是中药调节体温与缓解疼痛的潜在靶点。
- 29种寒热温凉平药性中药对TRP通道有调控作用。
- 中药调控TRP通道的分子机制尚待深入研究。
核心结论
- 中药及其活性成分可调控TRP离子通道,该作用被视为中药调节体温和缓解疼痛的靶点;但其分子机制仍需进一步研究。
研究设计与样本
- 综述类:围绕中药及其活性成分对TRP离子通道的调控作用进行文献汇总,并讨论中药寒热温凉平药性的研究方向。
主要发现
- 在寒热温凉平药性的中药中,共发现29种对TRP离子通道有调控作用的中药。
- 所列举中药包括肉桂、辣椒、大黄、博落回、薄荷、红景天等。
- TRPV1的发现获得诺贝尔奖,体现该类通道受关注的程度。
关键数值与推荐
- 纳入对TRP离子通道有调控作用的中药共29种,药性涵盖寒、热、温、凉、平。
临床怎么用
- 可将TRP通道调控作为理解中药寒热温凉平药性及止痛、调体温作用的参考方向,具体应用需结合进一步机制研究。
局限性
- 中药调控TRP离子通道的分子机制尚未阐明,仍需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In recent years, activation of thermal transient receptor potential (TRP) ion channels at a range of temperatures has received widespread attention as a target for traditional Chinese medicine (TCM) to regulate body temperature and relieve pain. Discovery of transient receptor potential vanilloid 1 (TRPV1) was awarded a Nobel Prize, reflecting the importance of these channels. Here, the regulatory effects of TCMs and their active ingredients on TRP ion channels are reviewed, and future directions for research on the cold, hot, warm, cool, and neutral natures of TCMs are considered. In herbs with cold, hot, warm, cool, and neutral natures, we found 29 TCMs with regulatory effects on TRP ion channels, including Cinnamomi Cortex, Capsici Fructus, Rhei Radix et Rhizoma, Macleayae cordatae Herba, Menthae Haplocalycis Herba, and Rhodiolae Crenulatae Radix et Rhizoma. Although some progress has been made in understanding the regulation of TRP ion channels by TCMs and their ingredients, the molecular mechanism by which TCMs have this effect remains to be further studied. We hope this review will provide a reference for further research on the cold, hot, warm, cool, and neutral natures of TCMs.
引用
- Yan S, Huang Y, Xiao Q, et al. Regulation of transient receptor potential channels by traditional Chinese medicines and their active ingredients. Front Pharmacol. 2022. PMID: 36313301. doi:10.3389/fphar.2022.1039412
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。